Skip to main content
SpringerLink
Log in

Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis

  • Review
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stamler JS, Vaccaro O, Ncaton JD, Wentworth D. Diabetes other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial.Diabetes Care 1993; 16: 434–44.

    Article  CAS  PubMed  Google Scholar 

  2. Krolewski AS, Kosinski EJ, Warram JH et al. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus.Am J Cardiol 1987; 59: 750–5.

    Article  CAS  PubMed  Google Scholar 

  3. Malmberg K, Ryden L, Hamsten A et al. Mortality prediction in patients with myocardial infarction: experiences from the DIGAMI study.Cardiovascular Research 1997; 34: 248–53.

    Article  CAS  PubMed  Google Scholar 

  4. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study.Circulation 1999; 99: 2626–32.

    CAS  PubMed  Google Scholar 

  5. Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, 11: cause-specific mortality in patients with insulin-treated diabetes mellitus.Diabetic Medicine 1999; 16: 466–71.

    Article  CAS  PubMed  Google Scholar 

  6. Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, 1: all-cause mortality in patients with insulin-treated diabetes mellitus.Diabetic Medicine 1999; 16: 459–65.

    Article  CAS  PubMed  Google Scholar 

  7. Deckert T, Yokoyama H, Mathiesen E et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic disease in patients with insulin-dependent diabetes.Br Med J 1996; 312: 871–4.

    CAS  Google Scholar 

  8. Coutinho M, Wang Y, Gerstein HC, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care 1999; 22: 233–40.

    Article  CAS  PubMed  Google Scholar 

  9. Lawson M, Tsui E, Gerstein D, Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis.Diabetes Care 1999; 22: 35B-39B.

    Google Scholar 

  10. The Diabetes and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med 1993; 329: 977–86.

    Article  Google Scholar 

  11. Epidemiology of Diabetes Interventions and Complications (ECID) Research Group. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes and complications.Diabetes 1999; 48: 383–90.

    Article  Google Scholar 

  12. Turner RC, Millns H, Neil Haw et al. Risk factors for coronary artery disease in non-insulin-dependent diabetes Mellitus: UK Prospective Diabetes Study (UKPDS:23).Br Med J 1998; 316: 823–8.

    CAS  Google Scholar 

  13. Lopes-Virella MF, Wohltmann HJ, Loadholt CB, Buse MG. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control.Diabetologia 1981; 21: 216–23.

    Article  CAS  PubMed  Google Scholar 

  14. Abraha A, Schultz C, Konopelska-Bahu T et al. Glycaemic control and familial factors determine hyperglycaemia in early childhood diabetes.Diabetic Medicine 1999; 16: 598–604.

    Article  CAS  PubMed  Google Scholar 

  15. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of LDL which increase its atherogenicity.N Engl J Med 1989; 320: 915–23.

    Article  CAS  PubMed  Google Scholar 

  16. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated lowdensity lipoprotein is more sensitive to oxidation: implications for the diabetic patient.Atherosclerosis 1993; 102: 63–7.

    Article  CAS  PubMed  Google Scholar 

  17. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH. Oxidation of low density lipoprotein in non-insulin dependent diabetes: Its relationship to fatty acid composition.Diabetologia 1995; 38: 1300–6.

    Article  CAS  PubMed  Google Scholar 

  18. Borkman M, Storlein LH, Pan DA et al. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids.N Engt J Med 1993; 328: 238–44.

    Article  CAS  Google Scholar 

  19. Madigan C, Ryan M, Owens D Collins P, Johnson A, Tomkin GH. Dietary unsaturated fatty acids in type 2 diabetes: Higher levels of atherogenic postprandial lipoproteins on a linoleic compared to an oleic acid-rich diet.Diabetes Care 2000; 1472–7.

  20. Ross R. Atherosclerosis — an inflammatory disease.N Engl J Med 1999; 340: 115–26.

    Article  CAS  PubMed  Google Scholar 

  21. Griffin XM, McInerny D, Collins P, Johnson A, Owens D, Tomkin GH. Autoantibodies to oxidised LDL are related to LDL fatty acid composition in diabetes.Diabetic Medicine 1997; 14: 741–7.

    Article  CAS  PubMed  Google Scholar 

  22. Festa A, Kopp HP, Schernthaner G, Menzel EJ. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications.Diabetologia 1998; 41: 350–6.

    Article  CAS  PubMed  Google Scholar 

  23. Eligini S, Colli S, Basso F, Sirone L, Tremoli E. Oxidised low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages.Arterioscler Thromb Vasc Biol 1999; 19: 1719–25.

    CAS  PubMed  Google Scholar 

  24. Karpe F, Steiner G, Uffelman K, Olivercrona T, Hamsten A. Postprandial lipoproteins and the progression of coronary atherosclerosis.Atherosclerosis 1994; 106: 83–97.

    Article  CAS  PubMed  Google Scholar 

  25. Gianturco SH, Ramprasad MP, Song R et al. Apolipoprotein B48 or its apolipoprotein B100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.Arterioscler Thromb Vasc Biol 1998; 18: 968–76.

    CAS  PubMed  Google Scholar 

  26. Gleeson A, Owens D, Collins P, Johnson A, Tomkin GH. The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model.Internat J Exp Diab Res 2000; 1: 203–10.

    Article  CAS  Google Scholar 

  27. Gylling H, Miettinen TA. Cholesterol absorption, synthesis and LDL metabolism in NIDDM.Diabetes Care 1997; 20: 90–5.

    Article  CAS  PubMed  Google Scholar 

  28. Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.Acta Diabetol 1996; 33: 205–10.

    CAS  PubMed  Google Scholar 

  29. Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH. The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes.Diabetic Medicine 1997; 14: 1051–8.

    Article  CAS  PubMed  Google Scholar 

  30. Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH. Improved metabolic control reduces the number of postprandial apolipoprotein B48-containing particles in type 2 diabetes.Atherosclerosis 2000; 148: 283–91.

    Article  CAS  PubMed  Google Scholar 

  31. Gleeson A, Anderton K, Owens D et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes.Diabetologia 1999; 42: 944–8.

    Article  CAS  PubMed  Google Scholar 

  32. Phillips C, Owens D, Collins P, Tomkin GH. Microsomal triglyceride transfer protein: The role of insulin resistance in the regulation of chylomicron assembly.Atherosclerosis 2002; 160: 355–60.

    Article  CAS  PubMed  Google Scholar 

  33. Tomkin GH. Robert Graves Memorial Lecture. Diabetes and atherosclerosis — a gut review.Ir f Med Sci 2002; 171 (2): 105–9.

    Article  CAS  Google Scholar 

  34. Pyorala K, Pedersen TR, Kjekshus J, Fraergeman O, Olsson AG, Thorgeirsson G. The Scandinavian Simvastatin Survival Study (4S) Group. Cholesterol-lowering with simvastatin improves prognosis of diabetic patients with heart disease.Diabetes Care 1997; 20: 614–20.

    Article  CAS  PubMed  Google Scholar 

  35. Sacks FM, Pfeffer MA, Move LA for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.N Engl J Med 1996; 335: 1001–9.

    Article  CAS  PubMed  Google Scholar 

  36. The Long-Term Intervention With Pravastatin In Ischaemic Heart Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.N Engl J Med 1988; 339: 1349–57.

    Article  Google Scholar 

  37. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary disease risk.Circulation 1990; 82: 495–6.

    CAS  PubMed  Google Scholar 

  38. Rubins HB, Robins SJ, Collins D et al. The veterans affairs high-density lipoprotein cholesterol intervention trial study group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol.N Engl J Med 1999; 341: 410–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diabetes and Endocrinology, Trinity College Dublin and The Adelaide and Meath Hospital, Dublin, Ireland

    G. H. Tomkin

Authors
  1. G. H. Tomkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. H. Tomkin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomkin, G.H. Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis. Ir J Med Sci 171, 161–164 (2002). https://doi.org/10.1007/BF03170507

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03170507

Keywords

Search

Navigation